Cresilon
PrivateLast Round
Seed Round
Apr 24, 2026
Est. Valuation
$93.5M
Total Funding Raised
$97.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cresilon operates in Healthcare & Life Sciences and is based in Brooklyn, New York. Its latest recorded funding round was a VC Round in September 2025.
Cresilon is a biotechnology company that develops, manufactures, and markets hemostatic medical devices using its proprietary plant-based hydrogel technology to control bleeding.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cresilon Comparables
Compare Cresilon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medcura, Inc. | 84% | |
| Starch Medical Inc. | 83% | |
| Marine Polymer Technologies | 82% |
For institutional investors. Book with your work email.
Cresilon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 24, 2026 | ||||
| Early Funding | Nov 21, 2025 | ||||
| VC Round | Sep 9, 2025 | ||||
| Series A | Apr 11, 2025 | ||||
| Series A-4 | Oct 27, 2022 | ||||
Series A Extension | Apr 8, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cresilon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paulson Investment Company | Series A, Series A-4 |
| Catalio Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 165% MoM, reaching 10.1K.
- Apr 24, 2026
Raised $5M in seed funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- signs_new_clientOct 26, 2026
Cresilon signs Afwerx as a new client through a Phase I SBIR contract focused on developing TRAUMAGEL for military personnel without immediate medical support, with work starting Jun. 22nd '26.
- signs_new_clientOct 26, 2026
On Oct 26th '26, Cresilon signs Air Force as a new client after the U.S. Air Force selects TRAUMAGEL through the AFWERX SBIR program for Phase I development to support hemorrhage control for military personnel without immediate medical support.
- attends_eventSep 30, 2026
Cresilon representatives will be on-site at EMS World Expo 2026 at booth #1321 in Florida from Sep 30th to Oct 1st '26, providing hands-on demonstrations of TRAUMAGEL's next generation and discussing its use for hemorrhage control.
For institutional investors. Book with your work email.
Cresilon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cresilon's valuation, stock price, and market status.
Is Cresilon a public or private company?
Cresilon is a private company.
What is the current stock price of Cresilon?
Cresilon is a private company, so its shares have no public market price. Caplight tracks Cresilon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cresilon worth (valuation)?
Cresilon's valuation is estimated at $93.5M based on funding round data.
Can I buy Cresilon stock?
Cresilon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cresilon's last funding round?
Cresilon's most recent funding round was Seed Round on April 24, 2026.
Who are the main investors in Cresilon?
Key investors in Cresilon include Paulson Investment Company.
Will Cresilon IPO soon?
No public IPO plans have been announced for Cresilon.
How can I track Cresilon secondary market activity?
Caplight tracks bids, offers, and trades in Cresilon's shares on secondary markets.